PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Curr Opin Otolaryngol Head Neck Surg. Author manuscript; available in PMC 2010 June 1.
Published in final edited form as:
PMCID: PMC2745635
NIHMSID: NIHMS130849

Effects of chemoradiotherapy on voice and swallowing

Abstract

Purpose of review

Chemotherapy has been found to result in comparable survival rates to surgery for head and neck cancer. However, toxicity can often be worse after chemoradiotherapy, with impairment in voice, swallowing, nutrition, and quality of life. Investigators are attempting to modify radiotherapy treatment regimens to spare organs that have an impact on swallowing. This review will highlight voice and swallowing impairment seen after chemoradiotherapy, as well as treatment for voice and swallowing disorders in this population. Results of newer radiotherapy regimens will also be highlighted.

Recent findings

Specific oropharyngeal swallowing motility disorders after chemoradiotherapy have been identified. Damage to specific structures has been correlated with specific pharyngeal phase swallow impairment. Swallowing function and quality of life have been examined over time, with improvement seen in both. Preventive/prophylactic swallow exercise programs have been encouraging. Chemoradiotherapy effects on voice have been identified in terms of acoustic, aerodynamic, and patient and clinician-rated perception of function. Improvement in voice has also been observed over time after chemoradiotherapy. Voice therapy has been found to have a positive impact on voice and perceptual measures in this population.

Summary

Current studies show some improvement in swallow function after swallow and voice therapy in patients treated with chemoradiotherapy. Further, there is a suggestion of improved swallow function with sparing of organs with specific radiotherapy protocols. Future research needs to focus on specific voice and swallow treatment regimens in the head and neck cancer patient treated with chemoradiotherapy, specifically, timing, frequency, duration, and specific treatment types.

Keywords: chemoradiotherapy, dysphagia, swallowing, voice

Introduction

Radiotherapy alone or in combination with chemotherapy is commonly used to treat cancer of the head and neck. However, dysphagia is a common sequela of treatment and may occur because of a variety of factors. Mucositis, nausea, lack of appetite, fatigue, reduced or altered taste, or tissue fibrosis can contribute to reduced eating ability and impaired quality of life (QoL) [13,4•]. Approximately 80% of patients undergoing radiotherapy develop mucositis [5]. Problems with chewing food, meal consumption time, pleasure in eating, xerostomia, trismus, sticky saliva, food sticking in the throat and mouth, and choking result in a major negative impact on QoL [13,4•,6].

Altered fractionation radiotherapy, concurrent chemoradiotherapy, and induction chemotherapy paired with chemoradiotherapy have shown improvement in local control and survival for head and neck cancer patients [711]. However, these treatments resulted in increased mucositis and swallowing impairment [12,13].

Radiotherapy may also impact on voice if the larynx is included in the treatment field. Radiotherapy to the larynx has been found to result in muscle atrophy, fibrosis, dryness of the laryngeal mucosa, hyperemia, and erythema [14,15]. Voice changes following radiotherapy may include reduced vocal loudness, low modal speaking pitch, reduced phonic breath support, vocal roughness, breathiness hoarseness, and vocal fatigue [1618]. Phonatory function testing revealed impairment in acoustic and aerodynamic voice measures [1921]. Voice variability and unpredictability after radiotherapy is a frequent complaint [22].

Effects of chemoradiotherapy on swallowing

Radiotherapy can have a major impact on oral and pharyngeal phase swallow functioning. Studies [2325,26••,27••] have found oral phase impairment includes reduced range of lingual motion, reduced lingual strength, impaired bolus formation, impaired bolus transport through the oral cavity, prolonged oral transit times, and increased oral residue percentages. Pharyngeal phase swallow impairment in this population can include impaired tongue base posterior movement, impaired velopharyngeal closure, delayed triggering of the pharyngeal swallow, reduced pharyngeal contraction, reduced hyoid and laryngeal motion, reduced laryngeal vestibule and glottic closure, and reduced opening of the upper esophageal sphincter, resulting in impaired bolus clearance and aspiration [23,24,27••,2832]. Specifically, the timing, strength, and coordination of pharyngeal structural movement contribute to reduced bolus clearance through the pharynx as well as aspiration, typically after the swallow and often silent [2837]. Research has shown that the cough reflex is impaired/absent in the irradiated head and neck cancer patient [38] Reduced tongue base and pharyngeal wall pressures have been found to correlate with impaired bolus clearance and pharyngeal residue that can be aspirated in head and neck cancer patients [39•]. Reduced lingual strength correlates with oral transit times, percentage oral residue, and oropharyngeal swallow efficiency (OPSE) [40], a global measure of swallow safety and efficiency [40], in a group of oral and oropharyngeal cancer patients treated with radio/chemoradiotherapy [25]. A follow-up study [26••] in this population examined the effects of chemoradiotherapy over a 12-month period. Interestingly, tongue strength did not correlate with swallow measures. However, there was a significant correlation between lingual strength and percentage oral intake in these patients. Tongue strength was significantly impaired 1-month postradiotherapy and improved over the course of the year. Diet type also followed this pattern [26••].

Other specific swallow motility disorders correlate with oral intake. Pauloski et al. [41] examined oral intake over a 12-month period. Swallow motility disorders significantly related to oral intake varied by evaluation point, with reduced tongue base retraction and reduced laryngeal elevation most related to oral intake at 1 month, delayed pharyngeal swallow, incomplete laryngeal vestibule closure, reduced laryngeal elevation and a rating of nonfunctional swallow at 3 months, and reduced cricopharyngeal opening at 6 and 12 months after chemoradiotherapy. This last disorder is not surprising, as cricopharyngeal stricture is frequently seen as a late swallowing impairment after primary chemoradiotherapy [33] as well as postoperative radiotherapy after total laryngectomy [42]. A recent study by Logemann et al. [43•] also examined swallow motility disorders in a group of 48 patients treated with radio/chemoradiotherapy over a 12-month period. Results indicated that oral and pharyngeal phase swallow motility disorders increased in frequency over the three time points, with frequency of functional swallow decreased significantly from baseline to 3 months after radiotherapy, with some improvement was seen by 12 months. Interestingly, Salama et al. [13] found that patients with more advanced T stages were less likely to have worsened swallow functioning and more likely to improve in swallow function after concurrent chemoradiotherapy. Additionally, these patients were more likely to demonstrate improvement in swallow functioning following completion of their treatment.

Newer strategies with intensity-modulated radiotherapy (IMRT) have been developed to spare structures related to swallowing. Eisbruch et al. [33] identified pharyngeal phase abnormalities that correlated with anatomic changes in pharyngeal structures, as examined by videoflouroscopy, endoscopy, and computed tomography imaging in patients after chemoradiotherapy to the head and neck. Structural damage to the pharyngeal constrictors and larynx was found. In this study, patients having undergone IMRT demonstrated sparing of these structures as compared with standard three-dimensional radiotherapy. Further, dosage of radiotherapy was found to correlate with swallow functioning and aspiration. A follow-up study by Feng et al. [44•] revealed similar findings in a group of nasopharyngeal and oropharyngeal cancer patients treated with chemo-IMRT, in which higher doses to the pharyngeal constrictors and glottic/supraglottic regions significantly correlated with impairment in bolus clearance through the pharynx secondary to reduced tongue base, pharyngeal constrictor, and laryngeal elevation for swallowing. This study highlights the need to further modify radiation dosage to spare swallowing structures.

Late effects of radiotherapy on swallowing

Dysphagia can occur long after completion of radiotherapy [30,31,45,46]. Patients with persistent dysphagia at least 1 year after treatment have been rated as having grades 5–7 (moderate-to-severe with aspiration) swallow impairment [46]. Studies have found impairment in swallowing up to 40 years after completion of treatment [47]. It is believed that tissue fibrosis contributes to impaired structural movement, with reduced overall extent (i.e., less than normal excursion/distance) and more sluggish movement [31]. Tongue strength and tongue base function for swallowing are impaired in patients with varied head and neck tumor sites treated with radiotherapy [45] and have been found as early and late impairment. It is clear that regardless of tumor locus, tongue function for swallowing can become impaired if the oropharynx is within the treatment volume due to neck disease. Tongue strengthening exercise programs might reduce the risk of long-term impairment. Advanced T stage has been found to be a risk factor related to severe late toxicity [48].

Malnutrition and weight loss have been found in patients treated with radio/chemoradiotherapy [4•,49,50]. In a retrospective study [49] examining long-term malnutrition and QoL in patients treated for head and neck cancer with surgery and adjuvant chemoradiotherapy, malnutrition rates were highest in patients treated with chemoradiotherapy. Further, QoL was worse in patients treated with chemoradiotherapy [49]. A prospective study [4•] assessing QoL and nutrition over 24 months in patients treated with chemoradiotherapy for nasopharyngeal cancer found a mean weight loss over the 24 months to be 8% (range 3–22%). Despite a significant drop in global health status over the 24-month period, QoL was stable or significantly improved. When examining toxic effects, significant correlations were found between dysphagia and social eating. Thus, nutritional support is critical to maintain adequate nutrition and QoL in these patients.

Voice after primary chemoradiotherapy: instrumental and perceptual assessment

Vocal fold lubrication and hydration are important for phonation. Voice problems after radiotherapy may be attributed to observable dryness of the laryngeal mucosa, muscle atrophy, fibrosis, hyperemia, and erythema. A recent study [51] of human laryngeal glands after radiotherapy found the average size and density of serous and mucous cells within laryngeal glands to be decreased and atrophic in the irradiated larynx. Thus, the quantity and quality of secretions is altered after irradiation, likely contributing to less lubrication of the vocal folds and subsequent voice problems. Several studies have examined QoL, acoustics, and patient and clinician-based perception of voice quality after radiotherapy or chemoradiotherapy. Voice-related QoL has been found to be better in patients after chemoradiotherapy compared with salvage laryngectomy [6,52]. When examining acoustic and perceptual voice measures after primary radiotherapy, several recent studies [23,53••,54•,55,56,57••] have found impairment of function, although severity varied. Electroglottographic (EGG) analyses of voice have revealed superior voice outcomes after primary chemoradiotherapy compared with patients with total laryngectomy and transesophageal puncture (TEP), with improvement over a 12-month period in the chemoradiotherapy group [54•]. In postradiotherapy nasopharyngeal cancer patients, EGG analysis of vocal fold vibratory behavior revealed higher speech quotient, a ratio of glottic opening time to closing time, and lower open quotient, an indication of longer closed phase relative to open phase in the cycle in these patients as compared with healthy controls [58]. Both of these measures reflect increased vocal tension or resistance [58]. These authors also found lower signal-to-noise ratios, indicative of voice abnormality [58]. Others have found abnormal perturbation scores and abnormal perceptual ratings in patients treated with radio/chemoradiotherapy to the larynx [23,53••,55,57••]. Abnormal measures of jitter, shimmer, harmonics-to-noise ratio, and fundamental frequency (i.e., increase in fundamental frequency) have been seen in irradiated laryngeal cancer patients as well [53••]. However, improvement in acoustic measures and QoL have been seen up to 12 months after treatment, though still below normal range [53••]. Patient-rated QoL using the Voice Handicap Index has revealed up to 87.8% with abnormal voice rating after irradiation to the larynx, although with slight-to-moderate dysfunction [56,57••]. Abnormal acoustic and aerodynamic measures are attributed to impairment of vocal fold vibration, as observed stroboscopically, with incomplete closure and reduced mucosal wave, as well as observed ventricular activity, the latter indicative of hyperfunction [57••].

Evaluation and treatment of swallowing problems after chemoradiotherapy

Instrumental examination of swallowing is critical when defining the physiologic swallowing abnormalities and determining whether therapeutic strategies might result in safer and more efficient swallowing in these patients. Instrumental techniques include the modified barium swallow procedure (videoflouroscopy) and flexible endoscopic evaluation of swallowing (FEES) [5963]. Therapeutic strategies utilized during these instrumental procedures include postures, swallow maneuvers, and sensory enhancements to improve swallow functioning [61,64]. Manometry is useful when examining oral and pharyngeal pressure generation and upper esophageal sphincter function during the swallow, particularly when paired with fluoroscopy to provide information on oral and pharyngeal structural movement simultaneous with pressure information [35,39•,65].

Swallow maneuvers can modify various aspects of the pharyngeal motor response. The Mendelsohn maneuver and Shaker exercise focuses on increasing the extent and duration of hyolaryngeal movement, thereby increasing the width and duration of upper esophageal sphincter opening [66,67]. The super supraglottic swallow maneuver assists in early airway closure (i.e., glottic and supraglottic) for added airway protection [64,68,69]. These maneuvers can not only improve the extent of pharyngeal structural movement but also improve timing and coordination of pharyngeal structural movement during swallowing [70,71]. The tongue-hold maneuver is designed to improve pharyngeal constrictor motion, which is frequently impaired in these patients [72].

Postures may change bolus flow through the oral cavity and pharynx, rather than alter swallow physiology. These include chin tuck, head back, head tilt, head rotation, and lying down to improve bolus flow and clearance through the oral cavity and pharynx [73]. They also afford greater airway protection (i.e., chin tuck and head rotation) as well as improved bolus clearance in unilateral oral and pharyngeal impairment [73]. Effects of postures and maneuvers are determined during the examination, as is specific swallow treatment to address the physiologic swallow disorders defined during the instrumental examination.

Patients after chemoradiotherapy often need to be followed for extended periods with the goal of return to optimal/normal diet, G-tube removal, or both. It is critical that patients are followed long after chemoradiotherapy to ensure adequate oral nutrition. Adding oral nutritional supplementation with weekly counseling by a registered dietician has had a positive impact on outcomes regarding weight loss and rate of percutaneous endoscopic gastrostomy (PEG) tube placement [74]. Nutritional supplement was associated with a 37% relative reduction in weight loss in patients treated with chemoradiotherapy. Weight loss has been found to correlate significantly with treatment interruption, early mortality, infection, hospital readmission, and survival in noncompliant patients [75]. Thus, it is critical that health professionals work as a team to achieve optimal nutritional status, swallow rehabilitation, and QoL.

Once patients have returned to optimal oral diet intake, it has become common practice to recommend continued daily practice of swallow exercises [45]. This is based on the current data regarding effects of radiotherapy on swallowing long after completion of treatment, as discussed previously. Unfortunately, patients are often reticent to practice if they feel their swallowing has improved or normalized and, therefore, need strong encouragement to practice to reduce the risk of swallowing problems at a later date.

Treatment of voice after chemoradiotherapy

Voice therapy following chemoradiotherapy focuses on vocal hygiene, direct voice therapy, and helping the patient to produce voice without using inefficient compensatory behaviors such as increased laryngeal strain and supraglottic constriction [22]. Few studies have examined outcome of voice therapy in irradiated patients. One recent study by van Gogh et al. [76••] examined the effect of voice therapy in patients treated with radiation for early glottic cancer. These authors examined a variety of measures and found voice therapy to be effective in a voice-therapy group as compared with randomly assigned control (no therapy) group. Patient self-rating with the Voice Handicap Index, clinician perceptual rating, as well as acoustic and videostroboscopic assessment were shown to improve after voice therapy [76••]. Perceptual ratings of vocal fry significantly decreased in the experimental group, as did jitter and harmonics-to-noise measures. Interestingly, there were no changes in vibratory function after therapy for either group, as observed stroboscopically. Clearly, there is a need for more studies examining the efficacy of voice therapy in the irradiated head and neck cancer patient.

Prevention of swallowing problems in patients undergoing chemoradiotherapy

Because approximately 44% of patients experience difficulty swallowing following chemoradiotherapy [77], it has become fairly common practice to provide preradiotherapy instruction in swallow exercises designed to preserve range, rate, coordination, and flexibility of the vocal tract musculature involved in swallowing [73]. These exercises focus on maintaining tongue, jaw, pharyngeal constrictor, hyolaryngeal elevation and anterior motion, airway closure, and upper esophageal sphincter opening. This treatment regimen typically includes tongue range of motion, tongue strengthening, tongue base range of motion [i.e., effortful swallow, tongue-hold maneuver, and tongue base retraction exercise (gargle)], jaw range of motion (as indicated), pharyngeal constrictor exercise (tongue-hold maneuver), hyolaryngeal elevation/upper esophageal sphincter opening exercises (Mendelsohn maneuver and Shaker exercise), and airway closure exercises (i.e., super supraglottic swallow). Patients are instructed to perform these exercises on a daily basis during chemoradiotherapy.

Data are emerging that support the efficacy of swallow exercise programs during radio/chemoradiotherapy. Two studies [78,79] have shown potential benefit to patients undergoing primary radio/chemoradiotherapy, with improvement in both QoL and pharyngeal phase swallow functioning as compared with control (no exercise) groups. Unfortunately, in one of these studies, PEG tube removal did not differ between groups, with no significant difference in ability to maintain oral nutrition. A recent randomized, controlled study [80] examined two types of swallow exercise programs (standard vs. standard and tongue strengthening exercises) in oral/oropharyngeal cancer patients administered 1 month after chemoradiotherapy. Results revealed no change in tongue strength between or across groups. However, improved QoL was seen in the treatment group as compared with controls [81].

Conclusion

The effects of chemoradiotherapy can have a major impact on swallowing, voice, and QoL. Dysphagia is only one of many variables that may have an impact on swallowing. Future studies are needed to determine optimal radiotherapy regimens to minimize oral, pharyngeal, and laryngeal structural damage that impacts voice and swallowing, as well as minimize side effects of chemoradiotherapy that impact oral intake such as mucositis, taste alterations, and appetite loss. Studies examining the utility of exercise programs during chemoradiotherapy on maintenance of swallowing are somewhat encouraging. However, future studies need to examine other swallow treatment paradigms, examining variables, including specific swallow exercise protocols, with focus on timing, frequency, and duration of exercise programs to optimize function for swallowing. Further, future studies should examine utility of swallow exercise programs on a long-term basis, for up to 5–10 years to determine whether swallow function and oral intake are maintained over time. Finally, additional studies examining the effects of specific voice therapy regimens in this population are needed, as are studies examining timing, frequency, and duration of treatment.

Acknowledgments

The author’s work was supported by a grant from NIDCD R03 DC007497-02.

References and recommended reading

Papers of particular interest, published within the annual period of review, have been highlighted as:

• of special interest

•• of outstanding interest

Additional references related to this topic can also be found in the Current World Literature section in this issue (pp. 000–000).

1. Hammerlid E, Mercke C, Sullivan M, Westin T. A prospective quality of life study of patients with l aryngeal carcinoma by tumor stage and different radiation therapy schedules. Laryngoscope. 1998;108:747–759. [PubMed]
2. De Graeff A, De Leeuw RJ, Ros WJG. A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck. 1999;21:291–296. [PubMed]
3. List MA, Siston A, Haraf D. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol. 1999;17:1020–1028. [PubMed]
4• . Oates JE, Clark JR, Read J. Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2007;133:533–540. This study examines QoL and nutrition prospectively in a group of nasopharyngeal cancer patients over a 24-month period. This study supports the need for ongoing nutritional support and rehabilitation in a multidisciplinary setting for patients treated with chemoradiotherapy. [PubMed]
5. Treister N, Sonis S. Mucositis: biology and management. Curr Opin Otolaryngol Head Neck Surg. 2007;15:123–129. [PubMed]
6. Boscolo-Rizzo P, Maronato F, Marchiori C. Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation. Laryngoscope. 2008;118:300–306. [PubMed]
7. Forestiere AA, Goepfert H, Maor M. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–2098. [PubMed]
8. Mendenhall WM, Stringer SP, Amdur RJ. Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue? J Clin Oncol. 2000;18:35–42. [PubMed]
9. Sessions DG, Lenox J, Spector GJ. Analysis of treatment results for base of tongue cancer. Laryngoscope. 2003;113:1252–1261. [PubMed]
10. Taylor SG, Murthy AK, Griem KL. Concomitant cisplatin/5-FU infusion and radiotherapy in advanced head and neck cancer: 8-year analysis of results. Head Neck. 1997;19:684–691. [PubMed]
11. Vokes EE, Kies M, Haraf DJ. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol. 1995;13:876–883. [PubMed]
12. Salama JK, Stenson KM, Kistner EO. Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multiinstitutional phase II trial investigating three radiotherapy dose levels. Ann Oncol. 2008;19:1787–1794. [PubMed]
13. Salama JK, Stenson KM, List MA. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2008;134:1060–1065. [PubMed]
14. Mendonca DR. State of the patient after successful irradiation for laryngeal cancer. Laryngoscope. 1975;85:534–539. [PubMed]
15. Kraus DH, Pfister DG, Harrison LB. Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer. Otolaryngol Head Neck Surg. 1994;111:31–37. [PubMed]
16. Stoicheff ML. Voice following radiotherapy. Laryngoscope. 1975;85:608–618. [PubMed]
17. Stoicheff ML, Ciampi A, Passi JE, Fredrickson JM. The irradiated larynx and voice: a perceptual study. J Speech Hear Res. 1983;26:482–485. [PubMed]
18. Morris MR, Canonico D, Blank C. A critical review of radiotherapy in the management of T1 glottic carcinoma. Am J Otolaryngol. 1994;15:276–280. [PubMed]
19. Lehman JJ, Bless DM, Brandenburg JH. An objective assessment of voice production after radiation therapy for stage I squamous cell carcinoma of the glottis. Head Neck Surg. 1988;98:121–129. [PubMed]
20. Miller S, Harrison LB, Solomon B, Sessions RB. Vocal changes in patients undergoing radiation therapy for glottic carcinoma. Laryngoscope. 1990;100:603–606. [PubMed]
21. Woo P, Colton RH, Shangold L. Phonatory airflow analysis in patients with laryngeal disease. Ann Otol Rhinol Laryngol. 1987;96:549–555. [PubMed]
22. Orlikoff RF, Kraus DH. Dysphonia following nonsurgical management of advanced laryngeal carcinoma. Am J Speech Lang Pathol. 1996;5:47–52.
23. Carrara-de Angelis E, Feher O, Barros APB. Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg. 2005;129:733–738. [PubMed]
24. Hughes PJ, Scott PMJ, Kew J. Dysphagia in treated nasopharyngeal cancer. Head Neck. 2000;22:393–397. [PubMed]
25. Lazarus CL, Logemann JA, Pauloski BR. Swallowing and tongue function following treatment for oral and oropharyngeal cancer. J Speech Lang Hear Res. 2000;43:1011–1023. [PubMed]
26•• . Lazarus CL, Logemann JA, Pauloski BR. Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing. Head Neck. 2007;29:632–637. This is the first prospective study to examine tongue strength and swallowing after radio/chemoradiotherapy over a 12-month period in oral and oropharyngeal cancer patients. Results indicated improvement in tongue strength and swallow function over time. [PubMed]
27•• . Logemann JA, Pauloski BR, Rademaker AW. Swallowing disorders in the first year after radiation and chemoradiation. Head Neck. 2008;30:148–158. This study examines specific swallow motility disorders over a 12-month period in patients after chemoradiotherapy. This study revealed that chemoradiation resulted in fewer functional swallowers than radiation alone at 12-month posttreatment completion. [PMC free article] [PubMed]
28. Eisele DW, Koch DG, Tarazi AE, Jones B. Aspiration from delayed radiation fibrosis of the neck. Dysphagia. 1991;6:120–122. [PubMed]
29. Kendall KA, McKenzie SW, Leonard RJ. Structural mobility in deglutition after single modality treatment of head and neck carcinomas with radiotherapy. Head Neck. 1988;20:720–725. [PubMed]
30. Kotz T, Abraham S, Beitler J. Pharyngeal transport dysfunction consequent to an organ-sparing protocol. Arch Otolaryngol Head Neck Surg. 1999;125:410–413. [PubMed]
31. Lazarus CL, Logemann JA, Pauloski BR. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope. 1996;106:1157–1166. [PubMed]
32. Smith RV, Kotz T, Beitler JJ, Wadler S. Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea. Arch Otolaryngol Head Neck Surg. 2000;126:384–389. [PubMed]
33. Eisbruch A, Schwartz M, Rasch C. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiation Oncol Biol Phys. 2004;60:1425–1439. [PubMed]
34. Ekberg O, Nylander G. Pharyngeal dysfunction after treatment for pharyngeal cancer with surgery and radiotherapy. Gastrointest Radiol. 1983;8:97–104. [PubMed]
35. Lazarus C, Logemann JA, Song CW. Effects of voluntary maneuvers on tongue base function for swallowing. Folia Phoniatr Logop. 2002;54:171–176. [PubMed]
36. Logemann JA. Aspiration in head and neck surgical patients. Ann Otol Rhinol Laryngol. 1985;94:373–376. [PubMed]
37. Smith CH, Logemann JA, Colangelo LA. Incidence and patient characteristics associated with silent aspiration in the acute care setting. Dysphagia. 1999;14:1–7. [PubMed]
38. Nguyen NP, Moltz CC, Fran C. Effectiveness of the cough reflex in patients with aspiration following radiation for head and neck cancer. Lung. 2007;185:243–248. [PubMed]
39• . Pauloski BR, Rademaker AW, Lazarus CL, et al. Relationship between manometric and videofluoroscopic measures of swallow function in healthy adults and patients treated for head and neck cancer with various modalities. Dysphagia. 2008 Epub ahead of print. This is the first study that correlates manometric and videofluoroscopic measures in a group of head and neck cancer patients treated with primary radio/chemoradiotherapy using simultaneous manometry and fluoroscopy. Videofluoroscopic variable of pharyngeal residue was correlated with pharyngeal pressures as measured manometrically. [PMC free article] [PubMed]
40. Rademaker AW, Pauloski BR, Logemann JA, Shanahan TK. Oropharyngeal swallow efficiency as a representative measure of swallowing function. J Speech Hear Res. 1994;37:314–325. [PubMed]
41. Pauloski BR, Rademaker AW, Logemann JA. Relationship between swallow motility disorders on videofluorography and oral intake in patients treated for head and neck cancer with radiotherapy with or without chemotherapy. Head Neck. 2006;28:1069–1076. [PubMed]
42. Vu KN, Day TA, Gillespie MB. Proximal esophageal stenosis in head and neck cancer patients after total laryngectomy and radiation. ORL J Otorhinolaryngol Relat Spec. 2008;70:229–235. [PubMed]
43• . Logemann JA, Pauloski BR, Rademaker AW. Swallowing disorders in the first year after radiation and chemo radiation. Head Neck. 2008;30:148–158. This prospective study examined a large cohort of patients treated with either radiotherapy or chemoradiotherapy over a 12-month period. Swallowing motility disorders were identified by videoflouroscopy. This study found those patients treated with chemoradiotherapy to demonstrate greater impairment in swallowing over time, with fewer functional swallowers as compared with the radiotherapy group. [PMC free article] [PubMed]
44• . Feng FY, Kim HM, Lyden TH. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007;68:1289–1298. This study examines the dose volume effect relationships to provide optimal IMRT to reduce dosage to swallowing structures and reduce dysphagia. Higher dosages to the pharyngeal constrictors and larynx resulted in worse swallow functioning. [PubMed]
45. Lazarus CL. Tongue strength and exercise in healthy individuals and head and neck cancer patients. Sem Speech Lang. 2006;4:260–267. [PubMed]
46. Nguyen NP, Moltz CC, Frank C. Long-term aspiration following treatment for head and neck cancer. Oncology. 2008;74:25–30. [PubMed]
47. Lazarus CL. Effects of radiation therapy and voluntary maneuvers on swallow function in head and neck cancer patients. Clin Commun Disord. 1993;3:11–20. [PubMed]
48. Machtay M, Moughan J, Trotti A. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582–3589. [PubMed]
49. Garcia-Peris P, Paron L, Velasco C, de la Cuerda C. Long-term prevalence of oropharyngeal dysphagia in head and neck cancer patients: impact on quality of life. Clin Nutr. 2007;26:710–717. [PubMed]
50. Newman LA, Robbins KT, Logemann JA. Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. Head Neck. 2002;24:68–77. [PubMed]
51. Sato K, Nakashima T. Effect of irradiation on the human laryngeal glands. Ann Otol Rhinol Laryngol. 2008;117:734–739. [PubMed]
52. Fung K, Lyden TH, Lee J. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys. 2005;63:1395–1399. [PubMed]
53•• . Bibby JRL, Cotton SM, Perry A, Corry JF. Voice outcomes after radiotherapy treatment for early glottic cancer: assessment using multidimensional tools. Head Neck. 2008;30:600–610. This prospective study used instrumental and clinician and client-rated perceptual measures to examine voice and voice-related QoL in patients after radiotherapy for early glottic cancer. Instrumental assessments including acoustic and aerodynamic voice measures were taken. [PubMed]
54• . Kazi R, Venkitaraman R, Johnson C. Electroglottographic comparison of voice outcomes in patients with advanced laryngopharyngeal cancer treated by chemoradiotherapy or total laryngectomy. Int J Radiat Oncol Biol Phys. 2008;70:344–352. This study compared acoustic voice measures after chemoradiotherapy and total laryngectomy. Results indicated better acoustic measures after chemoradiotherapy. [PubMed]
55. Rovirosa A, Ascaso C, Abellana R, et al. Acoustic voice analysis in different phonetic contexts after larynx radiotherapy for T1 vocal cord carcinoma. Clin Transl Oncol. 2008;10:168–174. [PubMed]
56. Šiupšinskienė N, Vaitkus S, Grėbliauskaitė M, et al. Quality of life and voice in patients treated for early laryngeal cancer. Medicina (Kaunas) 2008;44:288–295. [PubMed]
57•• . Sjögren EV, va Rossum MA, Langeveld TPM. Voice outcome in T1a midcord glottic carcinoma: laser surgery versus radiotherapy. Arch Otolaryngol Head Neck Surg. 2008;134:965–972. This study examined posttreatment voice quality in a group of patients after radiotherapy. Analysis was multidimensional and included perceptual, acoustic, aerodynamic, and stroboscopic assessment as well as patient self-rated assessment using the Voice Handicap Index. [PubMed]
58. Lin E, Hwang T, Hornibrook J, Ormond T. Voice of postradiotherapy nasopharyngeal carcinoma patients: evidence of vocal tract effect. J Voice. 2008;22:351–364. [PubMed]
59. Aviv JE, Thomson JE, Sunshine S, Close LG. Fiberoptic endoscopic evaluation of swallowing with sensory testing (FEESST) in healthy controls. Dysphagia. 1998;13:87–92. [PubMed]
60. Langmore S, Schatz K, Olsen N. Fiberoptic endoscopic examination of swallowing safety: a new procedure. Dysphagia. 1988;2:216–219. [PubMed]
61. Logemann JA. Rehabilitation of oropharyngeal swallowing disorders. Acta Otorhinolaryngol Belg. 1994;48:207–215. [PubMed]
62. Martin-Harris B, Logemann JA, McMahon S. Clinical utility of the modified barium swallow. Dysphagia. 2000;15:136–141. [PubMed]
63. Martin-Harris B, Michel Y, Castell DO. Physiologic model of oropharyngeal swallowing revisited. Otolaryngol Head Neck Surg. 2005;133:234–240. [PubMed]
64. Martin BJW, Logemann JA, Shaker R, Dodds WJ. Normal laryngeal valving patterns during three breath-hold maneuvers: a pilot investigation. Dysphagia. 1993;8:11–20. [PubMed]
65. McConnel FMS. Analysis of pressure generation and bolus transit during pharyngeal swallowing. Laryngoscope. 1988;98:71–78. [PubMed]
66. Kahrilas PJ, Logemann JA, Krugler C, Flanagan E. Volitional augmentation of upper esophageal sphincter opening during swallowing. Am J Physiol. 1991;260 (3 Pt 1):G450–G456. [PubMed]
67. Shaker R, Easterling C, Kern M. Rehabilitation of swallowing by exercise in tube-fed patients with pharyngeal dysphagia secondary to abnormal UES opening. Gastroenterology. 2002;122:1314–1321. [PubMed]
68. Logemann JA, Kahrilas PJ, Cheng J. Closure mechanisms of laryngeal vestibule during swallowing. Am J Physiol. 1992;262 (2 Pt 1):G338–G344. [PubMed]
69. Logemann JA, Pauloski BR, Rademaker AW, Colangelo L. Super-supraglottic swallow in irradiated head and neck cancer patients. Head Neck. 1997;19:535–540. [PubMed]
70. Lazarus C, Logemann JA, Gibbons P. Effects of maneuvers on swallowing function in a dysphagic oral cancer patient. Head Neck. 1993;15:419–424. [PubMed]
71. Steele CM, Huckabee ML. The Influence of orolingual pressure on the timing of pharyngeal pressure events. Dysphagia. 2007;22:30–36. [PubMed]
72. Fujiu M, Logemann JA. Effect of a tongue-holding maneuver on posterior pharyngeal wall movement during deglutition. Am J Speech Lang Patholy. 1996;5:23–30.
73. Lazarus CL. Management of swallowing disorders in head and neck cancer patients: optimal patterns of care. Semin Speech Lang. 2000;31:293–309. [PubMed]
74. Lee H, Gavrila C, Bravo V. Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma. Support Care Cancer. 2008;16:285–289. [PubMed]
75. Capuano G, Grosso A, Gentile PC. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck. 2008;30:503–508. [PubMed]
76•• . van Gogh CDL, Verdonck-de Leeuw IM, Boon-Kamma BA. The efficacy of voice therapy in patients after treatment for early glottic carcinoma. Cancer. 2006;106:95–105. This is the only randomized study examining effects of voice therapy on voice and QoL in patients treated with radiotherapy. Voice therapy was found to improve voice (using objective parameters and QoL) in these patients as compared with a control (no therapy) group. [PubMed]
77. Eisbruch A, Levendag PC, Feng FY. Can IMRT or brachytherapy reduced dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys. 2007;69:S40–S42. [PMC free article] [PubMed]
78. Kulbersh BD, Rosenthal EL, McGrew BM. Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life. Laryngoscope. 2006;116:883–886. [PubMed]
79. Carroll WR, Locher JL, Canon CL. Pretreatment swallowing exercises improve swallow function after chemoradiation. Laryngoscope. 2008;118:39–43. [PubMed]
80. Lazarus C. Tongue function in healthy and head and neck cancer patients. Chicago, Illinois. Annual American Speech Language Hearing Association Annual Meeting; 2008.
81. Prasse J, Sanfilippo N, Delacure M, et al. Tongue strength and swallowing in oral cancer patients. Presented at the 17th Annual Dysphagia Research Society Meeting; New Orleans, Louisiana. 2009.